Alicia Arnott

2.5k total citations
34 papers, 861 citations indexed

About

Alicia Arnott is a scholar working on Infectious Diseases, Public Health, Environmental and Occupational Health and Molecular Biology. According to data from OpenAlex, Alicia Arnott has authored 34 papers receiving a total of 861 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Infectious Diseases, 8 papers in Public Health, Environmental and Occupational Health and 7 papers in Molecular Biology. Recurrent topics in Alicia Arnott's work include SARS-CoV-2 and COVID-19 Research (9 papers), Malaria Research and Control (7 papers) and SARS-CoV-2 detection and testing (6 papers). Alicia Arnott is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (9 papers), Malaria Research and Control (7 papers) and SARS-CoV-2 detection and testing (6 papers). Alicia Arnott collaborates with scholars based in Australia, Spain and Papua New Guinea. Alicia Arnott's co-authors include Alyssa E. Barry, John C. Reeder, Vitali Sintchenko, Rebecca J. Rockett, Ivo Müeller, Peter M. Siba, Monica Naughtin, Vincent Deubel, Bertrand Guillard and Sareth Rith and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

Alicia Arnott

32 papers receiving 853 citations

Peers

Countries citing papers authored by Alicia Arnott

Since Specialization

Citations

This map shows the geographic impact of Alicia Arnott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alicia Arnott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alicia Arnott more than expected).

Fields of papers citing papers by Alicia Arnott

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alicia Arnott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alicia Arnott. The network helps show where Alicia Arnott may publish in the future.

Co-authorship network of co-authors of Alicia Arnott

This figure shows the co-authorship network connecting the top 25 collaborators of Alicia Arnott. A scholar is included among the top collaborators of Alicia Arnott based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alicia Arnott. Alicia Arnott is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Title	Journal	Authors	Indexed citations
1	Mpox genomics in outbreak control: challenges and limitations	The Lancet Microbe	Kathryn Edenborough, Eike Steinig et al.	1
2	Genome entropy and network centrality contrast exploration and exploitation in evolution of foodborne pathogens	Physical Biology	Sheryl L. Chang, C. J. E. Suster et al.	1
3	Emergent Omicron BR.2.1 sublineage of SARS-CoV-2 in New South Wales, Australia: a subvariant with high fitness but without increased disease severity	International Journal of Infectious Diseases	Annaleise R. Howard‐Jones, Alicia Arnott et al.	0
4	SABRes: in silico detection of drug resistance conferring mutations in subpopulations of SARS-CoV-2 genomes	BMC Infectious Diseases	Rebecca J. Rockett, Shona Chandra et al.	7
5	Improved Neutralisation of the SARS-CoV-2 Omicron Variant following a Booster Dose of Pfizer-BioNTech (BNT162b2) COVID-19 Vaccine	Viruses	Kerri Basile, Rebecca J. Rockett et al.	21
6	Genome-wide networks reveal emergence of epidemic strains of Salmonella Enteritidis	International Journal of Infectious Diseases	Adam J. Svahn, Sheryl L. Chang et al.	8
7	SARS-CoV-2 Within-Host and in vitro Genomic Variability and Sub-Genomic RNA Levels Indicate Differences in Viral Expression Between Clinical Cohorts and in vitro Culture	Frontiers in Microbiology	Mailie Gall, Connie Lam et al.	4
8	Added Value of Genomic Surveillance of Virulence Factors in Shiga Toxin-Producing Escherichia coli in New South Wales, Australia	Frontiers in Microbiology	Eby Sim, Ryan Kim et al.	5
9	Risk factors leading to COVID‐19 cases in a Sydney restaurant	Australian and New Zealand Journal of Public Health	Rebecca J. Rockett, Vicky Sheppeard et al.	6
10	Documenting elimination of co-circulating COVID-19 clusters using genomics in New South Wales, Australia	BMC Research Notes	Alicia Arnott, Jenny Draper et al.	7
11	Genomic Surveillance Enables Suitability Assessment of Salmonella Gene Targets Used for Culture-Independent Diagnostic Testing	Journal of Clinical Microbiology	Rebecca J. Rockett, Alicia Arnott et al.	7
12	NovelSalmonella entericaSerovar Typhimurium Genotype Levels as Herald of Seasonal Salmonellosis Epidemics	Emerging infectious diseases	Qinning Wang, Alicia Arnott et al.	6
13	Plasmodium vivax Populations Are More Genetically Diverse and Less Structured than Sympatric Plasmodium falciparum Populations	PLoS neglected tropical diseases	Charlie Jennison, Alicia Arnott et al.	63
14	Strategies for Designing and Monitoring Malaria Vaccines Targeting Diverse Antigens	Frontiers in Immunology	Alyssa E. Barry, Alicia Arnott	76
15	Distinct patterns of diversity, population structure and evolution in the AMA1 genes of sympatric Plasmodium falciparum and Plasmodium vivax populations of Papua New Guinea from an area of similarly high transmission	Malaria Journal	Alicia Arnott, Johanna Wapling et al.	32
16	Global Population Structure of the Genes Encoding the Malaria Vaccine Candidate, Plasmodium vivax Apical Membrane Antigen 1 (PvAMA1)	PLoS neglected tropical diseases	Alicia Arnott, Ivo Müeller et al.	51
17	Human bocavirus amongst an all‐ages population hospitalised with acute lower respiratory infections in Cambodia	Influenza and Other Respiratory Viruses	Alicia Arnott, Sirenda Vong et al.	18
18	Understanding the population genetics of Plasmodium vivax is essential for malaria control and elimination	Malaria Journal	Alicia Arnott, Alyssa E. Barry et al.	97
19	Genetic variability of human metapneumovirus amongst an all ages population in Cambodia between 2007 and 2009	Infection Genetics and Evolution	Alicia Arnott, Sirenda Vong et al.	54
20	High Viral Fitness during Acute HIV-1 Infection	PLoS ONE	Alicia Arnott, Darren Jardine et al.	18

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact